asc2escalate: phase ii dose-escalation study of second-line asciminib in patients with cml-cp
Published 1 year ago • 90 plays • Length 1:53Download video MP4
Download video MP3
Similar videos
-
1:04
phase i/ii study of bosutinib in newly diagnosed & resistant/intolerant pediatric patients with cml
-
1:39
update on a phase i/ii study of ziftomenib in patients with r/r aml
-
6:31
an overview of trials investigating asciminib in the treatment of ph cml
-
1:46
asciminib versus other tkis in the frontline treatment of cml: the asc4first study
-
2:03
preliminary results of a phase ii study of fedratinib in patients with mds/mpn and cnl
-
2:34
asciminib plus dasatinib for the treatment of ph b-all: insights from a phase i trial
-
1:52
results of phase i study of mcl-1 inhibition with azd5991 in r/r hematologic malignancies
-
4:03
a phase i/ii study evaluating quizartinib plus decitabine and venetoclax in flt3-mutated aml
-
15:59
phylogenomic branch length estimation using... - yasamin tabatabaee - evolcompgen - ismb/eccb 2023
-
16:47
preliminary data using hyperoxia and multiparametric qbold to estimate oxygen extraction fraction
-
12:02
isp module iii rerecord 20220404 1350 1
-
3:56
results of the phase ii titan study of caplacizumab in patients with attp
-
5:24
safety by treatment phase and age when treating flt3-itd-mutated aml with quizartinib and chemo
-
1:02
a phase ii single-arm study of obinutuzumab plus ibrutinib as frontline treatment for fl and mzl
-
2:58
results of a phase ib study of ibrutinib obinutuzumab in r/r cll
-
4:48
an insight into the management of cytopenias in mf
-
1:49
phase ii trial-in-progress of itacitinib in patients with myelofibrosis
-
2:07
analysis of long-term exposure to momelotinib in the phase iii simplfy myelofibrosis trials
-
6:31
a meta-analysis assessing the safety of cytoreductive therapies in younger patients with pv
-
1:32
an update from bellwave-001: nemtabrutinib in cll/sll
-
![apical 4-chamber view at the time of atypical rbbb - supplementary video 2 [id 269576]](https://i.ytimg.com/vi/wLhml7zbtNc/mqdefault.jpg)
0:09
apical 4-chamber view at the time of atypical rbbb - supplementary video 2 [id 269576]
-
5:41
primary results from the phase iii shine study: ibrutinib br for older patients with mcl